These findings support the notion that the BM B cell compartment is functionally modulated in response to nonmetastatic tumor burden, with specific enrichment of an OPG-producing phenotype among IgD+ IgM+ CD138− B cells, in accordance with previous findings (8). The gene discussed is TNFRSF11B; the disease is neoplasm.